- Report
- July 2022
- 100 Pages
Global
From €2651EUR$2,750USD£2,267GBP
- Report
- November 2018
- 105 Pages
Global
From €4290EUR$4,450USD£3,669GBP
- Report
- June 2021
- 54 Pages
Global
€21210EUR$22,000USD£18,140GBP
- Report
- March 2021
- 40 Pages
Global
€21210EUR$22,000USD£18,140GBP
- Report
- October 2020
- 51 Pages
Global
€21210EUR$22,000USD£18,140GBP
- Report
- October 2018
- 15 Pages
Global
From €9641EUR$10,000USD£8,245GBP
- Report
- October 2018
- 22 Pages
Global
From €9641EUR$10,000USD£8,245GBP
- Drug Pipelines
- January 2018
- 18 Pages
Global
From €9641EUR$10,000USD£8,245GBP
- Drug Pipelines
- January 2018
- 16 Pages
Global
From €9641EUR$10,000USD£8,245GBP
- Drug Pipelines
- January 2018
- 27 Pages
Global
From €9641EUR$10,000USD£8,245GBP
- Drug Pipelines
- January 2018
- 13 Pages
Global
From €9641EUR$10,000USD£8,245GBP
- Report
- December 2022
- 168 Pages
Global
From €2410EUR$2,500USD£2,061GBP
- Report
- March 2020
- 120 Pages
Global
From €2410EUR$2,500USD£2,061GBP
- Report
- December 2019
- 104 Pages
Asia Pacific
From €8672EUR$8,995USD£7,417GBP
- Report
- December 2018
- 125 Pages
Global
From €7708EUR$7,995USD£6,592GBP
- Report
- August 2022
- 100 Pages
Global
From €4623EUR$4,795USD£3,954GBP
- Report
- May 2022
- 40 Pages
Argentina
From €2502EUR$2,595USD£2,140GBP
- Report
- May 2022
- 40 Pages
Poland
From €2502EUR$2,595USD£2,140GBP
From €2502EUR$2,595USD£2,140GBP
- Report
- May 2022
- 40 Pages
United Kingdom
From €2502EUR$2,595USD£2,140GBP
Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more